Inhalon Doses First Patient in Phase 1 Study of Inhaled IN-006 to Treat COVID-19
DURHAM - Inhalon Biopharma, Inc., a clinical-stage immunotherapy company developing an inhaled "muco-trapping" antibody platform for treating ...
Read moreDURHAM - Inhalon Biopharma, Inc., a clinical-stage immunotherapy company developing an inhaled "muco-trapping" antibody platform for treating ...
Read moreNEW DELHI(INDIA) - India has come up with an effective idea to fight the world's biggest ...
Read moreBENGALURU (INDIA): With India’s new COVID cases staying above 300,000 for a sixth consecutive day, the ...
Read moreBANGKOK (THAILAND) - Amid a sharp increase in infections in Bangkok, at least 10 Thai cabinet ...
Read moreBERLIN (GERMANY): Just a day after she asked the country to forgive her U-turn on a ...
Read moreCANBERRA (AUSTRALIA) - A dangerous outbreak of coronavirus has been detected at Papua New Guinea (PNG) ...
Read morePARIS (FRANCE) - As the seven-day average of new cases rose above 25,000 for the first ...
Read moreTHE HAGUE (NETHERLANDS) - A crowd of several thousand people who addressed themselves as anti-lockdown protesters ...
Read moreThousands of Rangers fans gathered at the club's stadium, training ground and George Square in Glasgow's ...
Read moreTOKYO (JAPAN) - Considering the risks posed by the spread of COVID-19, Japan is considering limiting ...
Read more